News Focus
News Focus
icon url

frrol

10/21/23 5:01 PM

#436296 RE: Steady_T #436295

Biotech's not for everyone.
icon url

mrplmer

10/21/23 7:53 PM

#436309 RE: Steady_T #436295

I suggest it'd been a year since results for AD. It is the franchise T!
icon url

crescentmotor

10/21/23 9:30 PM

#436318 RE: Steady_T #436295

Rett will be filed before AD and Rett approval will make Anavex a revenue producing company.



Rett is what is keeping me sane when it comes to AVXL. My personal share price projections (only back of envelope stuff) show an AVXL price after two years into commercialization at $80/share. That assumes a slow ramp with a very conservative number of treatments.